Log In
BCIQ
Print this Print this
 

APC-200, CPC-200

  Manage Alerts
Collapse Summary General Information
Company Colby Pharmaceutical Co.
DescriptionOral small molecule that blocks androgen-induced hydrogen peroxide production and inflammation and inhibits mouse Pca
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationProstate cancer
Indication DetailsTreat castrate-sensitive prostate cancer; Treat castration-resistant prostate cancer (CRPC)
Regulatory Designation
PartnerAdamis Pharmaceuticals Corp.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/08/2010

Undisclosed

0

0

Get a free BioCentury trial today